Literature DB >> 18268142

Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction.

Monica Salio1, Stefano Chimenti, Noeleen De Angelis, Fabiola Molla, Virginia Maina, Manuela Nebuloni, Fabio Pasqualini, Roberto Latini, Cecilia Garlanda, Alberto Mantovani.   

Abstract

BACKGROUND: Despite widespread clinical use as a prognostic marker in ischemic heart disorders, the actual pathogenetic role of the short pentraxin, C-reactive protein, has not undergone stringent genetic testing because of evolutionary divergence between mouse and humans. The long pentraxin PTX3 is conserved in evolution, is expressed in the heart under inflammatory conditions, and is a candidate prognostic marker in acute myocardial infarction. It was therefore important to assess whether PTX3 plays a pathogenetic role in acute myocardial infarction. METHODS AND
RESULTS: In a model of acute myocardial infarction caused by coronary artery ligation and reperfusion, tissue mRNA expression and circulating levels of PTX3 increased. The interleukin-1R-MyD88 pathway plays a pivotal role in the induction of PTX3 transcript after ischemia. ptx3-deficient mice showed exacerbated heart damage (33% larger infarcts in null mice; P=0.0047). Increased myocardial damage in ptx3-deficient mice was associated with a greater no-reflow area, increased neutrophil infiltration, decreased number of capillaries, and increased number of apoptotic cardiomyocytes. In addition, ptx3-deficient mice with acute myocardial infarction showed higher circulating levels of interleukin-6 and increased C3 deposition in lesional tissue. The phenotype was reversed by exogenous PTX3.
CONCLUSIONS: Thus, PTX3 plays a nonredundant, regulatory, cardioprotective role in acute myocardial infarction in mice. Our results suggest that modulation of the complement cascade contributes to the cardioprotective function of PTX3.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18268142     DOI: 10.1161/CIRCULATIONAHA.107.749234

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  138 in total

1.  Effects of telmisartan on markers of ventricular remodeling in patients with acute myocardial infarction: comparison with enalapril.

Authors:  Takashi Yokota; Tomohiro Osanai; Kenji Hanada; Motoi Kushibiki; Naoki Abe; Koichi Oikawa; Hirofumi Tomita; Takumi Higuma; Jin Yokoyama; Hiroyuki Hanada; Ken Okumura
Journal:  Heart Vessels       Date:  2010-10-05       Impact factor: 2.037

2.  Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3.

Authors:  Tiziano Barbui; Alessandra Carobbio; Guido Finazzi; Alessandro M Vannucchi; Giovanni Barosi; Elisabetta Antonioli; Paola Guglielmelli; Alessandro Pancrazzi; Silvia Salmoiraghi; Pio Zilio; Cosimo Ottomano; Roberto Marchioli; Ivan Cuccovillo; Barbara Bottazzi; Alberto Mantovani; Alessandro Rambaldi
Journal:  Haematologica       Date:  2010-12-20       Impact factor: 9.941

3.  Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Ruth Dubin; Michael Shlipak; Yongmei Li; Joachim Ix; Ian H de Boer; Nancy Jenny; Carmen A Peralta
Journal:  Nephrol Dial Transplant       Date:  2010-11-15       Impact factor: 5.992

4.  Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study.

Authors:  Ruth Dubin; Yongmei Li; Joachim H Ix; Michael G Shlipak; Mary Whooley; Carmen A Peralta
Journal:  Am Heart J       Date:  2012-02       Impact factor: 4.749

5.  Long pentraxin PTX3 deficiency worsens LPS-induced acute lung injury.

Authors:  Bing Han; Jack J Haitsma; Yu Zhang; Xiaohui Bai; Matthew Rubacha; Shaf Keshavjee; Haibo Zhang; Mingyao Liu
Journal:  Intensive Care Med       Date:  2010-11-12       Impact factor: 17.440

Review 6.  Translational mini-review series on immunology of vascular disease: mechanisms of vascular inflammation and remodelling in systemic vasculitis.

Authors:  N Maugeri; P Rovere-Querini; M Baldini; M G Sabbadini; A A Manfredi
Journal:  Clin Exp Immunol       Date:  2009-03-20       Impact factor: 4.330

7.  Pregnancy-associated genes contribute to antiluteolytic mechanisms in ovine corpus luteum.

Authors:  Jared J Romero; Alfredo Q Antoniazzi; Natalia P Smirnova; Brett T Webb; Fang Yu; John S Davis; Thomas R Hansen
Journal:  Physiol Genomics       Date:  2013-09-17       Impact factor: 3.107

8.  Pentraxin 3 inhibits acute renal injury-induced interstitial fibrosis through suppression of IL-6/Stat3 pathway.

Authors:  Yuefei Xiao; Nainin Yang; Qingxian Zhang; Yiping Wang; Songtao Yang; Zhanxiao Liu
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

9.  Relationship between Plasma Pentraxin-3, Neutrophil-to-Lymphocyte Ratio, and Atherosclerosis in Renal Transplant Patients.

Authors:  Kultigin Turkmen; Fatih Mehmet Erdur; Ibrahim Guney; Huseyin Ozbiner; Aysun Toker; Abduzhappar Gaipov; Orhan Ozbek; Mehdi Yeksan; Halil Zeki Tonbul; Suleyman Turk
Journal:  Cardiorenal Med       Date:  2012-11-16       Impact factor: 2.041

10.  Pentraxin 3 as a novel marker predicting congestive heart failure in subjects with acute coronary syndrome.

Authors:  Dong-Hyeon Lee; Hui-Kyung Jeon; Ji-Han You; Mi-Yeon Park; Seung-Jae Lee; Sung-Sik Kim; Byung-Joo Shim; Yun-Seok Choi; Woo-Seung Shin; Jong-Min Lee; Chul-Soo Park; Ho-Joong Youn; Wook-Sung Chung; Jae-Hyung Kim
Journal:  Korean Circ J       Date:  2010-08-31       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.